Aaron Hansen

Division of Medical Oncology

UHN - Princess Margaret Hospital

Aaron Hansen

Sign the Guestbook

All messages are held for moderation.


Dr. Hansen is an expert in the assessment of patient-reported outcome measures (PROMs) in clinical trials of novel anticancer pharmacotherapies, in particular immune-related adverse events associated with cancer immunotherapies (checkpoint inhibitors). He developed the tools necessary for assessment of patient-reported outcomes in clinical trials of cancer therapies and successfully advocated for their inclusion at earlier phases of new drug development.